CEBPA and leukemia: For example, our final causal gene set included GBAS (for its causal network, see Text S1), a gene that was reported amplified in more than 40% of glioblastomas [30], [31] and CEBPA (enhancer binding protein) that was amplified in about 10% of leukemia cases [32].